Vireo Growth Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation British Columbia, Canada
Business Address 207 SOUTH 9TH STREET, MINNEAPOLIS, MN, 55402
Mailing Address 207 SOUTH 9TH STREET, MINNEAPOLIS, MN, 55402
Phone 604-617-5421
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2024
-$28.01M
Net Income
$278.86M
Total Assets
$199.31M
Total Liabilities
$55.56M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 8-K Current report of material events | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 8-K Current report of material events | December 29, 2025 | View on SEC |
| 8-K Current report of material events | December 22, 2025 | View on SEC |
| 8-K Current report of material events | December 10, 2025 | View on SEC |
| S-3 Shelf registration for future offerings | December 9, 2025 | View on SEC |
Material Events
8-K Acquisition December 22, 2025
High Impact
- Vireo Growth Inc., through its subsidiary, is acquiring cannabis dispensary assets in Colorado from PharmaCann Inc.
- The acquisition is valued at approximately $49 million, primarily paid with Vireo's company shares, and includes taking on some of PharmaCann's related debts.
8-K Acquisition December 10, 2025
High Impact
- Vireo Growth Inc., through its subsidiary, acquired a majority of Medicine Man Technologies, Inc. (Schwazze) assets.
- The acquisition was executed via a 'credit bid' using approximately $111 million of Schwazze's Senior Secured Convertible Notes during its restructuring process.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.